Literature DB >> 2722569

Evidence that dopaminergic sympathetic axons supply the medullary arterioles of human kidney.

C Bell1, P S Bhathal, R Mann, G B Ryan.   

Abstract

The ability of the kidney to excrete sodium appears to depend on release of dopamine from intrarenal sources. In the present study, we have used immunohistochemistry to examine the possibility that renal dopaminergic nerves constitute one of these sources. We found that the sympathetic axons supplying cortical structures in human kidney contain tyrosine hydroxylase-like immunoreactivity but lack DOPA decarboxylase-like immunoreactivity. By contrast, the vasa recta arterioles of the renal medulla are supplied by varicose tyrosine hydroxylase-positive nerve fibres, some of which also contain DOPA decarboxylase. As DOPA decarboxylase has been demonstrated in other situations to be a selective marker for dopaminergic terminal axons, our results suggest the innervation of renal medullary blood vessels in man by both noradrenergic and dopaminergic sympathetic nerves.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2722569     DOI: 10.1007/BF00493822

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  21 in total

Review 1.  Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.

Authors:  L I Goldberg; Y Y Hsieh; L Resnekov
Journal:  Prog Cardiovasc Dis       Date:  1977 Jan-Feb       Impact factor: 8.194

2.  The innervation of the renal cortex in the dog. An ultrastructural study.

Authors:  M Ferguson; G B Ryan; C Bell
Journal:  Cell Tissue Res       Date:  1988-09       Impact factor: 5.249

3.  Spectrum of deranged sodium homeostasis in essential hypertension.

Authors:  M Epstein; R Loutzenhiser; R Levinson
Journal:  Hypertension       Date:  1986-05       Impact factor: 10.190

4.  Dopaminergic and noradrenergic sympathetic nerves of the dog have different DOPA decarboxylase activities.

Authors:  T Harris; B Muller; R G Cotton; C Borri Voltattorni; C Bell
Journal:  Neurosci Lett       Date:  1986-04-11       Impact factor: 3.046

5.  The effect of carbidopa administration on urinary sodium excretion in man. Is dopamine an intrarenal natriuretic hormone?

Authors:  S G Ball; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

Review 6.  Endogenous renal dopamine and control of blood pressure.

Authors:  C Bell
Journal:  Clin Exp Hypertens A       Date:  1987

7.  Two classes of sympathetic nerves with different dopa decarboxylase immunoreactivities exist in dog vas deferens.

Authors:  C Bell; R Mann; C Borri Voltattorni
Journal:  Neurosci Lett       Date:  1987-10-16       Impact factor: 3.046

8.  Relationship between urinary dopamine production and natriuresis after acute intravascular volume expansion with sodium chloride in dogs.

Authors:  J R Sowers; P D Crane; F W Beck; M McClanahan; M E King; P K Mohanty
Journal:  Endocrinology       Date:  1984-12       Impact factor: 4.736

9.  Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man.

Authors:  R W Alexander; J R Gill; H Yamabe; W Lovenberg; H R Keiser
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

Review 10.  MPTP toxicity: implications for research in Parkinson's disease.

Authors:  I J Kopin; S P Markey
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

View more
  3 in total

1.  Extrinsic denervation elevates neuronal aromatic L-amino acid decarboxylase immunoreactivity in rat small intestine.

Authors:  R Mann; C B Voltattorni; C Bell
Journal:  Histochemistry       Date:  1989

2.  Aminergic innervation of the gall bladder in man and dog.

Authors:  R Mann; P S Bhathal; C Bell
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

3.  Sympathetic innervation of the liver in man and dog: an immunohistochemical study.

Authors:  R Mann; P S Bhathal; C Bell
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.